The oral glucose tolerance test (OGTT) identifies a proportion of people who have a diabetic post-challenge blood glucose, but a non-diabetic fasting value. The prevalence of isolated post-challenge hyperglycaemia (IPH) is variable but has been reported to account for as much as 70 % of all undiagnosed diabetes in elderly women [1] and is also common amongst the non-obese [2] .
ing data from three longitudinal population based studies.
Subjects and methods
The populations studied were in Mauritius, an Indian Ocean island, Fiji and Nauru (both in the Pacific). In Mauritius, approximately 70 % of the population is of Asian Indian origin, 2 % Chinese and 28 % ªgeneral populationº who are predominantly people of African ancestry (Creoles) with varying European, Malagasy and Indian admixture. In Fiji, the population is of Indian (49 %) and Melanesian (46 %) origin, and the Nauruan population is over 90 % Micronesian. The Mauritian survey included adults aged 25±74 years, and the other two surveys included all adults aged 20 years and above. In all three surveys, over 90 % of participants were under the age of 65. Each of the surveys was population based and had a response rate of over 80 %.
Each of the three baseline surveys was done in a similar manner, and detailed descriptions have been published previously [4±6] . Briefly, all eligible adults were asked to attend a survey site between 0800 and 1000, after an overnight fast. Following registration, all participants had fasting blood samples taken and all, except those on treatment for diabetes, had an OGTT (75 g dextrose monohydrate in 250 ml water). Fasting and 2±h plasma glucose concentrations were determined immediately on site with a YSI glucose analyser (Yellow Springs, Ohio, USA). For this analysis, classifications of diabetes were based on the recent American Diabetes Association recommendations [3] . IPH was defined as fasting plasma glucose (FPG) < 7.0 mmol/l and 2-h plasma glucose (2 h-PG) ³ 11.1 mmol/l. Isolated fasting hyperglycaemia (IFH) was defined as FPG ³ 7.0 mmol/l and 2 h-PG < 11.1 mmol/l. Combined hyperglycaemia (CH) was defined as FPG ³ 7.0 mmol/l and 2 h-PG ³ 11.1 mmol/l. Those with a history of diabetes were classified as known diabetes (KDM), and the non-diabetic population (FPG < 7.0 mmol/l and 2 h-PG < 11.1 mmol/l) served as the reference population.
Blood pressure was measured after a 5 min rest, with the participant sitting, using the first and fifth Korotkoff sounds recorded to the nearest 2 mmHg. Blood pressure was recorded twice, and the mean value was used. Hypertension was diagnosed on the basis of World Health Organization (WHO) criteria (systolic blood pressure ³ 160 mmHg and/or diastolic blood pressure ³ 95 mmHg) or of self reported antihypertensive medication taken in the past week. Height and weight were measured in light clothing without shoes, and the body mass index (BMI) was calculated as weight (kg)/height (m) 2 . Information on mortality was collected from death certificates in each country and coded according to the International Classification of Diseases (ICD) ninth revision codes [7] . ICD codes 401±414 and 426±444 were used for cardiovascular disease (CVD) deaths, and 140±239 for cancer deaths. In Nauru, the baseline survey was done in 1982, and the vital status of all 1576 survey participants was determined in 1994. During this period, all death certificates for the island were examined. The baseline survey in Fiji was done in 1980, and follow-up until 1991 was carried out by a specially trained nurse doing house-to-house visits and regular surveillance of medical records. Death certificates of those reported to have died were traced, and in 1991, vital status was known for 96.5 % of the cohort. The baseline survey in Mauritius was done in 1987. Vital status was determined by household interviews in 1989 and 1992 for 99.5 % of the 1987 cohort. Death certificates were traced for those reported to have died.
Statistical analysis. Statistical analysis was done with SPSS 8.0 software (SPSS, Inc., Ill., USA). The data from the three surveys were pooled and analysed as a single cohort. Mortality percentages from each glucose category were age-standardized to the whole study population by the direct method. The Cox proportional hazards model was used to determine the mortality risk associated with each category of diabetes. Potential confounders were forced into the models, unless stated otherwise in the text.
Results
At baseline, there were 9297 participants (5083 from Mauritius, 2638 from Fiji, 1576 from Nauru), and vital status was available in 9179 (98.7 %) at follow-up (Table 1). At baseline, there were 243 people with IPH representing 31 % (30 % for men, 32 % for women) of the newly diagnosed diabetic population and 18 % (17 % for men, 18 % for women) of the total diabetic population.
The median follow-up for survivors was 5.0 years, and there were 848 deaths. Table 2 shows the number of deaths in each category of diabetes for all causes as well as for CVD and cancer. Amongst the 1379 people with diabetes at baseline, there were 370 deaths of which 140 were due to CVD, 85 were attributed directly to diabetes, and 39 to cancer. Amongst those with IPH at baseline there were 50 deaths accounting for 5.9 % of all deaths and 13.5 % of deaths amongst people with diabetes at baseline.
For the 243 people with IPH, the median (interquartile range) FPG was 6.0 (5.4±6.4) mmol/l, and for the 50 IPH people who died it was 5.7 (5.0±6.3) mmol/l. Table 3 and Figure 1 show the mortality risk for the different categories of diabetes as determined by Data are numbers (%). Percentages are age-standardized to the whole study population by the direct method outcomes screening for and aggressive management of Type II diabetes is promoted [3] . Data from the UKPDS now indicate that the latter may be successful [12, 13] . If screening concentrates on the fasting state only, as recommended by the ADA [3), then people whose only abnormality is in the post-load state will be missed. Such people are common [2] , especially amongst elderly populations [1] . What has not been clear is how important IPH is. Recently, IPH was found to be a major risk factor for cardiovascular death in elderly women in one study [1] and for death from any cause in men aged 60±79 [14] .
We have now shown that in a mixed population of Asian Indians, Pacific Islanders and people of African origin followed over 5±12 years, IPH was a strong predictor of mortality in both men and women. The data in Table 3 are adjusted for ethnicity and survey site and hence account for differences between the three populations. In addition, when the three populations were analysed separately (data not shown), IPH remained a risk factor for total mortality (significant for Mauritius and Fiji) and cardiovascular mortality (significant for Fiji). The risk of all cause and cardiovascular mortality was at least as strong for IPH as it was for those with abnormalities in both the fasting and post-load state (CH) and only slightly lower than the risk in previously diagnosed diabetes, although the width of the confidence intervals precludes accurate ranking. Note that there was no significant risk associated with IFH. This is possibly partly due to its relative infrequency in this cohort but is consistent with a recent study of elderly Americans [15] in which the prevalence of cardiovascular disease was similar in normoglycaemic people and those with IFH (24 % vs 22 %) and higher in people with IPH (31 %). In the Hoorn study, however, people with IFH had abnormal blood pressure and lipids [16] , and in two other cohorts, after 20 years of follow-up, excess mortality was shown in men with IFH [17] .
A surprising result was the strong risk of cancer death in men (and perhaps also women) with IPH. Conflicting results have previously been reported on the possible link between diabetes and cancer. In a 12-year study of 20 000 men and women in Chicago [18] , a high blood glucose 1 h after a 50 g glucose challenge was a risk factor for cancer death, but known diabetes was not. Some studies have also reported that diabetes is a risk factor for cancer death [17, 19, 20] , but in an analysis of more than 18 000 men from the Whitehall study over 18 years [21] neither hyperglycaemia nor known diabetes were risk factors for cancer death, except from pancreatic cancer. Other prospective studies have also failed to find a link between diabetes and cancer [22±24] . If, as our data suggest, the risk of cancer is concentrated in those people with IPH then the variability of the prevalence of IPH, and failure to analyse this group separately from other people with diabetes would be expected to produce varying results in different studies.
There is no obvious explanation for the association of IPH with cancer, and the relatively small number of events precludes analysis by type of cancer. Isolated post-challenge hyperglycaemia is more common in lean rather than obese people and might simply be a marker for weight loss. Indeed, in our study, the baseline BMI was lower (though not significantly) in those IPH men who died of cancer than in either those who survived or those who died of CVD. The association between IPH and cancer death, however, remained after adjusting for BMI and after excluding deaths in the first 2 years of follow-up (data not shown), suggesting that IPH is not just a marker for weight loss.
The accuracy of death certificates in describing the true cause of death is known to be limited and this may partly explain the high proportion of deaths that were attributed directly to diabetes. Whilst this possibly affects the confidence in the associations that we have reported with specific causes of death, the high total mortality in IPH remains a sound and important finding.
In summary, our study, like the two previous studies [1, 14] , shows that IPH is a common form of diabetes and increases mortality in magnitude similar to that of other forms of diabetes. By definition, people with IPH would not be classified as being diabetic by their fasting glucose and over 50 % of them would not even be classified as having impaired fasting glucose. Thus, the OGTT would be the only way to identify their real hyperglycaemic risk. We believe and recommend that the OGTT still has an important part to play in identifying those people at risk of diabetes related complications, especially the elderly in whom IPH is common.
